- Founded
- 2013
- Employees*
- 1-10
- Funding to Date*
- $2.3M
- Website
- knox.co
Before Aluna, patients had no way of objectively tracking their Asthma to understand triggers, measure lung function, and predict Asthma attachs.
Aluna’s platform empowers patients and clinicians to create personal action plans for their Asthma with FDA-cleared combination of a digital spirometer, a healthtracking platform, and a physician remote monitoring portal. They are currently fulfilling orders from clinicians at UCSF and family practice across the US. By enabling telemedicine Aluna has shown clinicians can intervene quickly when patients scores decrease and prevent severe symptoms.
With 41M patients suffering from Asthma or COPD, and use for COVID lung health recovery monitoring, Aluna is poised to be the solution for respiratory monitoring and care.